Broker Tips: Hikma Pharmaceuticals, Unilever, Rentokil Initial, Flutter Entertainment
The analysts of Berenberg raised their price target on the drugmaker Hikma Pharmaceuticals from 1,960.0p to 2,000.0p on Tuesday, citing greater stability in its generics division. Berenberg said Hikma had a “solid finish to 2023” across all three divisions, with guidance roughly 300 basis points ahead of consensus group revenue estimates, mainly due to the …
Broker Tips: Hikma Pharmaceuticals, Unilever, Rentokil Initial, Flutter Entertainment Read More »